Novavax stock sinks after proposed $125 million share sale, convertible debt offering

Must read

DISTANT’s New Single Is Industrial Deathcore At Its Finest

Distant's new single "Human Scum" falls somewhere in the middle of...

MANOWAR Revising Epic New Material After Their New Album’s Narrator Passes Away

Manowar just released their new and largely narrative EP The Revenge...

Buy These 2 Oilfield Services Stocks for Over 40% Upside Potential, Says Analyst

Yogi Bera would remind us that predictions are difficult, especially about the future – and that pearl of wisdom is more relevant than ever...

Shares of COVID-19 vaccine maker Novavax Inc. on Wednesday sank 11% after the company announced a proposed offering to sell millions of its debt and stock. The company said the proceeds could go toward the global launch of its Nuvaxovid COVID vaccine and the repayment or repurchase of some of the $325 million of its convertible debt due in February. Novavax announced a proposed sale of up to $125 million in stock, and said it expects to grant the underwriters a 30-day option to buy up to an additional $18.75 million of its stock. In conjunction with the share offering, Novavax on Wednesday also announced a proposed $125…

More articles

Latest article

Oil Markets In Flux As Embargo Deepens; China, India Demand Russian Discounts

Two of what threatened to be huge oil market shake-ups in a year of seismic industry change took a back seat Monday, as...

Saudi Arabia just said they are now ‘open’ to the idea of trading in currencies besides the US dollar — does this spell doom...

Saudi Arabia just said they are now 'open' to the idea of trading in currencies besides the US dollar — does this spell doom...

Tesla Drops Out of the 10 Biggest U.S. Public Companies

This copy is for your personal, non-commercial use only. To order presentation-ready copies...